I also want to put on record that I think Pharmac, as a model, is a very effective one, but we've known for years that three things Pharmac needed: it needed more money, it needed to make decisions in a more timely manner, and it needed to be more transparent about those decisions. Dr Reti and I have made these points very clear to the chair of the Pharmac Board in annual reviews over the last few years—the Hon Steve Maharey—and we got those assurances back. But today's report, I think, makes it very clear that there is a great deal of work to do.